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Abstract. The anionic form of arylsulphatase B (arylsulphatase Bm) was purified to apparent
homogeneity from monkey brain through steps involving chromatography on
diethylaminoethyl-cellulose, Blue-Sepharose, Biogel HTP and finally Biogel P-300 gel
filtration. The molecular weight of the purified enzyme as deduced by gel filtration on Biogel P- 
300 and by sodium dodecylsulphate gel electrophoresis was ~ 30,000. Escherichia coli alkaline
phosphatase treatment of arylsulphatase Bm resulted in the conversion of upto 84% of the
enzyme into a less charged form of enzyme, that could not bind to diethylaminoethyl cellulose.
Potassium phosphate an inhibitor of alkaline phosphatase prevented this conversion. Upon 
acid hydrolysis the purified enzyme yielded approximately 7·0 mol of inorganic phosphate per
mol of protein. Vibrio cholerae neuraminidase treatment did not alter the charge on
arylsulphatase Bm. 
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Introduction
 
The importance of arylsulphatases A and B stems from their absence in the human
genetic disorders metachromatic leukodystrophy and Maroteaux-Lamy syndrome
(Austin et al., 1963; Fluharty et al., 1975). The physiological substrates for ar-
ylsulphatases A and B were identified as cerebroside sulphate and UDP-N acetyl 
galactosamine-4-sulphate respectively. A minor anionic form of arylsulphatase B
termed arylsulphatase Bm which is found in the primate brain and which shows many
properties of arylsulphatase B is of particular interest for the following reasons (i) It is
found in a phosphorylated form only in the primate (human and monkey) brain but not
in the brain of other species like rat, chicken or rabbit (J. Mathew and A. S.
Balasubramanian, unpublished data), (ii) It is not found in the liver of primates (Stevens
et al., 1977; J. Mathew and A. S. Balasubramanian, unpublished data) and (iii)An
anionic form of arylsulphatase B termed arylsulphatase B1 found in transplantable
tumours of athymic mice has been reported to be both phosphorylated and sialylated
(Gasa et al., 1981).
Arylsulphatase Bm has not been purified and characterized so far. We report here its
purification from monkey brain and some of its characteristics which suggest that it is a 
phosphoprotein. 
 
Abbreviations used: DEAE, Diethylaminoethyl; SDS, sodium dodecyl sulphate.
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Materials and methods 
 
Blue-Sepharose was prepared by coupling Cibacron Blue F3GA (Ciba Geigy) to
Sepharose 6B (Ahmad et αl., 1977). Biogel HTP and Biogel P-300 were from BioRad,
USA, sodium metaperiodate from J. T. Baker, Phillipsburg, New Jersey, USA, and
Escherichia coli alkaline phosphatase (Type III) from Sigma Chemicals, St. Louis,
Missouri, USA. All other chemicals were obtained as described earlier (Lakshmi and
Balasubramanian, 1980).
 
 
Purification of the enzyme
 
Unless otherwise mentioned all operations were done at 0-4°C. Monkey (Macaca 
radiata) brain (70g) kept frozen at – 18°C was thawed and homogenized with 5
volumes of 20 mM Tris-HCl, buffer pH 7·4 in a Waring blendor and centrifuged at 
12000 g for 30 min. The supernatant was dialysed against 100 volumes of the same
buffer for 24 h.
 
 
Diethyl aminoethyl (DEAE) -Cellulose ion exchange chromatography
 
The dialysed supernatant was loaded on a column packed with precycled DEAE-
cellulose (26×4·5 cm), washed with 20 mM Tris-HCl buffer, pH 7·4 and eluted with a
linear gradient of 0–0·2 M NaCl in the same buffer. Fractions of 25 ml were collected. 
By this method arylsulphatase B, Bm and A were completely separated from each other
(Lakshmi and Balasubramanian, 1980). The active fractions of arylsulphatase Bm were
pooled and dialysed against 100 volumes of 20 mM Tris-acetate buffer pH 6·5.
 
 
Blue Sepharose affinity chromatography
 
The dialysed fraction of arylsulphatase Bm from DEAE-cellulose column was loaded 
on a Blue-Sepharose column (8·2×2·8 cm) equilibrated with 20 mM Tris-acetate buffer 
pH 6·5, washed with the same buffer and with 20 mM Tris-HCl buffer pH 7·4.The
enzyme was eluted with 20 mM Tris-HCl buffer pH 7·4/0·25 M NaCl. Fractions of 5 ml
were collected and the active fractions were pooled.
 
 
Hydroxyapatite chromatography
 
The pooled fractions of arylsulphatase Bm from the previous step was dialysed against
10 mM Tris-acetate buffer pH 6·5 and loaded on a Biogel HTP column (6·5×2·0 cm)
equilibrated with the same buffer. The column was initially washed with the loading
buffer, then with 0·1 M potassium phosphate buffer pH 7·5 and the enzyme eluted with
0·25 M potassium phosphate buffer pH 7·5. The eluate (60 ml) was dialysed for 2 h
against 120 volumes of 20 mM Tris-HCl buffer pH 7·4 with one change. The enzyme
concentrated against Aquacide II to 1·5 ml was redialysed exhaustively against the same
buffer to remove the phosphate completely.
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Gel filtration on Biogel P-300
 
The concentrated enzyme from the previous step was layered on a Biogel P-300 column
(26·5×2·1 cm) equilibrated with 20mM Tris-HCl buffer pH 7·4/0·15 M NaCl.
Fractions of 2 ml were collected at a flow rate of 8 ml/h. The active fractions were
pooled, concentrated against Aquacide II and dialysed against 20 mM Tris-HCl buffer
pH 7·4. 
 
 
Polyacrylamide gel electrophoresis
 
The concentrated eluate (12 µg) from Biogel P-300 column was subjected to Poly-
acrylamide gel electrophoresis under non-denaturing conditions in the Davis system
(Davis, 1964) as described earlier (Lakshmi and Balasubramanian, 1980). The protein
was stained with Coommassie Brilliant Blue G250 according to the method of
Holbrook and Leaver (1976). 
 
 
Molecular weight determination by sodium dodecyl sulphate (SDS) gel electrophoresis
and gel filtration on Biogel P-300 
 
Twenty µg of the purified enzyme containing 2% (w/v) SDS with 5% (v/v) 2-
mercaptoethanol was boiled for 2 min and subjected to gel electrophoresis according to
the method of Laemmli (1970). The electrophoretic mobility was compared against
standards of known molecular weights—human IgG (150,000), bovine serum albumin
(62,000), ovalbumin (43,000) and soybean trypsin inhibitor (21,000).
The molecular weight of the enzyme was also determined by gel filtration on Biogel
P-300 by comparing the Ve/Vo values with those of the standard marker proteins used
in the SDS gel electrophoresis.
 
 
Treatment with E. coli alkaline phosphatase
 
E. coli alkaline phosphatase treatment of the Bm enzyme (obtained after the Blue- 
Sepharose chromatography step) was carried out as follows. The incubation mixture in 
a final volume of 2·0 ml contained the enzyme protein, 10 mM MgCl2,100 mM Tris- 
acetate buffer pH 8·0 and E. coli alkaline phosphatase (2 units/mg protein). After 
incubation for 3 h or 5 h at 37°C, the mixture was dialysed against 100 volumes of 
20 mM Tris-HCl buffer pH 7·4 with 4 changes and loaded on a DEAE-cellulose column
(9·8 cm×0·8 cm) equilibrated with the same buffer. The column was washed, eluted 
with 0·2 M NaCl in the buffer and the fractions were assayed using nitrocatechol 
sulphate as substrate. In the case of the purified Bm enzyme, the incubation mixture 
contained 17·4µg protein, 1 unit of alkaline phosphatase, 10 mM MgCl2 and 100 mM 
Tris-acetate buffer pH 8·0 in a final volume of 10 ml. After an incubation period of 1 h, 
it was dialysed and passed through a DEAE-cellulose column (7·5 cm×0·8 cm) as
before. The fractions were assayed for activity using 4-methyl umbelliferyl sulphate as 
substrate. 
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Treatment with Vibrio cholerae neuraminidase
 
The Blue-Sepharose eluate of arylsulphatase Bm (1.36 mg protein) was incubated with
V. cholerae neuraminidase (0·1 unit) in the presence of 5 mM CaCl2 and 100 mM
sodium-acetate buffer pH 5·5 for 1 h at 37°C. The incubation mixture after dialysis
against 20 mM Tris-HCl buffer pH 7·4 was passed through a DEAE-cellulose column
and eluted as described for the phosphatase treatment.
 
Treatment with sodium metaperiodate
 
The Bm enzyme (DEAE-cellulose fraction, 1·7 mg protein) was concentrated by
Aquacide II and dialyzed against 10 mM phosphate buffer, pH 6·0. It was incubated 
with 10 mM sodium metaperiodate for 2 h at 4°C in the dark. Ethylene glycol (0·1 ml)
was added to arrest the reaction and dialysed against 20 mM Tris- HCl buffer pH 7·4.
Incubation of the enzyme with periodate for periods longer than 2 h resulted in
considerable loss of activity (about 80% loss for 6 h). The mixture was passed through a
DEAE-cellulose column and eluted as described for phosphatase treatment.
 
Acid hydrolysis of purified arylsulphatase Bm
 
The homogeneous arylsulphatase Bm (29 µg) was hydrolysed with 6 NHCl at 110°C for
8 h in a sealed pyrex hydrolysis tube. After hydrolysis, the sample was dried by repeated
evaporation under vacuum over KOH to remove HCl completely and the phosphate
liberated was quantitated by the method of Chen et al. (1956).
 
Enzyme assays
 
The incubation mixture for arylsulphatase Bm contained 7·5 mM nitrocatechol
sulphate, 0·2 M sodium-acetate buffer, pH 5·5 and the enzyme in a total volume of
0·2 ml. One unit of enzyme activity corresponds to 1 µmοl of nitrocatechol released/h 
(Lakshmi and Balasubramanian, 1980). 
In experiments where 4-methyl umbelliferyl sulphate was used as the substrate, the 
incubation mixture contained 2·5 mM 4-methyl umbelliferyl sulphate, 0·2 M sodium-
acetate buffer, pH 5·5 and the enzyme in a total volume of 0·2 ml. After incubation at
37°C for 4 h, the reaction was stopped by the addition of 1·0 ml of 0·4 M glycine-NaOH
buffer, pH 10·5 and the fluorescence of 4-methyl umbelliferone was measured in a
Hitachi 204-A fluorescence spectrometer (Stevens et al., 1977).
Protein was measured according to Lowry et al. (1951) using crystalline bovine serum
albumin as standard.
 
Results and discussion
 
 
Purification of arylsulphatase Bm
 
Table 1 shows the purification data of a typical batch of arylsulphatase Bm from
monkey brain. The enzyme at the final step of gel filtration on Biogel P-300 was 87 fold
,,, 
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Table 1. Purification of arylsulphatase Bm from monkey brain
 
* 1 unit = 1 µmοl nitrocatechol released/h.
 
 
purified with an overall recovery of 11·5% over the DEAE-cellulose fraction. The
enzyme moved as a single diffuse band on Polyacrylamide gel electrophoresis under 
non-denaturing conditions and as a sharp band under denaturing conditions in the 
presence of SDS. The final yield varied with different batches of purification. This was
mainly due to the varying recoveries obtained at the step of Blue-Sepharose
chromatography. It should also be mentioned that the final purified enzyme was very
labile. Storage of the enzyme at 4°C for 24 h resulted in 90% loss of activity. Addition of
2-mercapto-ethanol or bovine serum albumin did not stabilize the enzyme.
 
 
Molecular weight determination 
 
The molecular weight of the purified enzyme by SDS Polyacrylamide gel elec- 
trophoresis and by gel filtration on Biogel P-300 was found to be 30,000 and 33,000 
respectively. Arylsulphatase B (concentrated DEAE-cellulose fraction) was also found 
to have a molecular weight comparable to that of arylsulphatase Bm on Biogel P-300 gel
filtration.
 
 
Treatment with E. coli alkaline phosphatase and V. cholerae neuraminidase
 
The elution profile of the arylsulphatase Bm enzyme (obtained after Blue-Sepharose 
chromatography) subjected to E. coli alkaline phosphatase treatment is shown in figure 
1A. About 76% and 84% of the enzyme was converted to a less acidic presumably 
dephosphorylated form after 3 h and 5 h of incubation respectively. The near absence of 
any dephosphorylated enzyme in the control experiments upto 5 h of incubation was
suggestive of the absence of any endogenous phosphatase activity. When E. coli
phosphatase treatment was done in the presence of 100 mM potassium phosphate 
buffer, pH 8·0 (an inhibitor of alkaline phosphatase) there was no conversion of
arylsulphatase Bm into the less charged form (not shown in figure).
About 21% of the purified arylsulphatase Bm was converted into an unbound 
dephosphorylated form on DEAE-cellulose chromatography after treatment with E.
coli alkaline phosphatase for 1 h. Longer incubation periods was not possible because
the purified Bm enzyme lost activity rapidly at 37°C. 
Unlike phosphatase, neuraminidase treatment did not result in the conversion of the
arylsulphatase Bm into a less acidic form unbound to DEAE-cellulose column (figure
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Figure 1. Profile of arylsulphatase Bm on DEAE-cellulose column chromatography when 
subjected to (A) Phosphatase (B) neuraminidase and (C) periodate treatment. (A) Blue 
Sepharose eluted arylsulphatase Bm incubated with alkaline phosphatase for 3 h (∆) and 5 h 
(?); without alkaline phosphatase for 5 h (O). (B) Blue Sepharose eluted arylsulphatase Bm 
incubated with (?) and without (O ) neuraminidase for 1 h. (C) DEAE-cellulose eluted 
arylsulphatase Bm incubated with (?) and without (O) sodium metaperiodate at 4°C for
2 h. Details of procedure are given under Materials and methods.
 
 
1B). Sodium metaperiodate treatment failed to bring about any significant change in the
elution profile of the enzyme on DEAE-cellulose (figure 1C).
The dephosphorylated arylsulphatase Bm showed the same molecular weight as the
phosphorylated enzyme on Biogel P-300 gel filtration.
 
Phosphate content of the purified enzyme
 
The homogenous enzyme upon acid hydrolysis yielded 7·01 mol of inorganic 
phosphorus/mol protein. This quantitative estimation of phosphorus confirmed the 
phosphorylated state of arylsulphatase Bm. 
The present studies indicate that arylsulphatase Bm of brain differs from ar-
ylsulphatase B1 of transplantable lung tumours (Gasa et al., 1981) in its molecular
weight and in its non-susceptibility to neuraminidase action. Although the phos-
phorylated nature of purified arylsulphatase Bm has been suggested by the present
experiments, the nature of the phosphate residues remains to be determined. Periodate
treatment which is known to result in the oxidation of carbohydrate residues failed to
<, 
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alter the elution profile of arylsulphatase Bm. However this experiment does not 
completely exclude the presence of sugar phosphate residues (such as mannose-6- 
phosphate) because the sugar phosphate may still remain attached to the enzyme after 
periodate treatment. Serine, threonine or tyrosine phosphate residues are known to be
present in a number of phosphoproteins. Gasa and Makita (1983) have recently shown
the presence of phosphorylated residues on both the protein and carbohydrate moieties
in arylsulphatase B1. Attempts to label the Bm enzyme with 32P and analyze the
phosphorylated residues are under way now.
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